US Drug Store Chains Offer OTCs At Drive-Through Windows To Promote Social Distancing

Walgreens, CVS and Rite Aid encourage social distancing by offering OTC drugs and vitamins in drive-through services previously limited to Rx drugs windows. Walgreens also is restricting purchases of some items to prevent shortages.

Isolated sign advertising 'Drive-Thru Pharmacy' in capitals font directs drivers with arrow. Signage on brick pedestal grass empty road winter trees in background

Promoting social distancing as well as increasing customer convenience is behind making consumer health products available in drive-through services usually reserved for Rx drugs at Walgreen Co., CVS Health Corp. and Rite Aid Corp. stores.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Retail

Germans Favor Bricks-And-Mortar Pharmacy Over Mail-Order For OTCs

 
• By 

Almost two thirds (62%) of respondents to an online survey said they would rather buy non-prescription medicines in a local pharmacy than via a mail-order pharmacy, Pharma Deutschland reports.

JCPenney’s Online Beauty Shopper Conversion, Order Value Jump Thanks To Virtual Try-On

 

Retailer JC Penney Company, Inc.’s use of Revieve Inc.’s virtual try-on and beauty advisor tools has driven significant increases in online engagement, average order rates and conversion rates for makeup, skin and hair care versus the retailer’s other e-commerce products.

False Advertising Challenges To OTC Phenylephrine Efficacy Ineffective Against Federal Preemption

 

Although FDA concluded OTC oral phenylephrine is ineffective as a nasal decongestant in doses up to highest studied level, federal preemption precludes challenges to agency’s regulation of labeling for phenylephrine and other Rx and OTC drugs, according to recent decision in New York federal court.

Bausch + Lomb Results Enhance Acquisition Image

 

Firm’s future, as a separate business nearly 90% owned by Bausch Health, or as a standalone with different ownership or one not controlled by a majority owner, claims high profile in analysts’ comments and predictions. B+L is in the driver’s seat, they say.

More from Business

KKR Expands Health & Beauty Portfolio With Deal For Sweden’s Karo

 
• By 

Consumer health player Karo is changing hands from EQT to KKR in a deal thought to value the Stockholm-based firm at over €2.5bn.

‘The Only Certainty Is Uncertainty’ In The UK’s Consumer Health Market

 
• By 

While uncertainty might reign in the UK consumer health market - which grew by by 8% to £4.1bn ($5.3bn) in 2024 - “opportunity is everywhere” according to NielsenIQ health and beauty insights manager Alex Heffernan.

France’s Boiron Looks To Future After Challenging Year

 
• By 

The homeopathy specialist reported a big decline in profits in 2024 as a move to restructure its ailing French operation hit the bottom line.